Pegvisomant Side Effects
Brand Names: Somavert
Please note - some side effects for Pegvisomant may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Side Effects of Pegvisomant - for the Consumer
Pegvisomant
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Pegvisomant:
Seek medical attention right away if any of these SEVERE side effects occur when using Pegvisomant:Back pain; diarrhea; dizziness; flu-like symptoms (eg, mild fever or chills, muscle aches, weakness); nausea; pain, redness, or itching at the injection site; sinus inflammation.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; swelling of the legs and feet; symptoms of liver problems (eg, yellowing of the skin or eyes, dark urine, pale stools, unusual tiredness, severe or persistent nausea or stomach pain, loss of appetite); thickening of the skin or lumps at the injection site; unusual weight gain.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
TopSide Effects by Body System - for Healthcare Professionals
Hepatic
During premarketing clinical studies two patients (0.8%) had elevations of serum concentrations of alanine aminotransferase and aspartate aminotransferase greater than 10 times the upper limit of normal. In both patients, the transaminase elevations normalized after discontinuation of the drug. In other studies, up to 12% of patients experienced abnormal liver function tests.
Hepatic side effects have included abnormal liver function tests (elevations of serum concentrations of alanine aminotransferase and aspartate aminotransferase) in up to 12% of patients treated.
Immunologic
Immunologic side effects have included the development of low titer non-neutralizing antigrowth hormone antibodies.
General
General side effects have included infection (23 to 33%), pain (8 to 23%), flu syndrome (12 to 21%), and accidental injury (8 to 18%).
Musculoskeletal
Musculoskeletal side effects have included back pain (8%) and chest pain (4%).
Respiratory
Respiratory side effects have included sinusitis (8%).
Gastrointestinal
Gastrointestinal side effects have included diarrhea (4%) and nausea (8%).
Nervous system
Nervous system side effects have included headache (26%), dizziness (8%) and paresthesias (7%).
Cardiovascular
Cardiovascular side effects have included hypertension (8%) and peripheral edema (8%).
Local
Local side effects have included injection site reactions (11%).
Metabolic
Metabolic side effects have included hypercholesterolemia (14%). Lipohypertrophy has been reported in lass than 5% of patients following pegvisomant administration.
TopMore Pegvisomant resources
- Pegvisomant Professional Patient Advice (Wolters Kluwer)
- Pegvisomant MedFacts Consumer Leaflet (Wolters Kluwer)
- Pegvisomant Monograph (AHFS DI)
- pegvisomant Subcutaneous Advanced Consumer (Micromedex) - Includes Dosage Information
- Somavert Prescribing Information (FDA)
- Somavert Consumer Overview
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
